Medical imaging is the process of making a visual representation of the interior of the body for medical intervention. These instruments help in establishing a database of normal anatomy and physiology of internal organs so that any abnormality can be noticed immediately. The ability to create pictures of a patientinternal anatomy and convert them to film through diagnostic imaging has revolutionized the way many diseases and injuries are detected, diagnosed, and treated. This market has applications in various medical fields like cardiology, oncology, neurology, and orthopedics. Globally, most of the industrialized countries are spending a large part of their GDP on healthcare requirements. The US is set to spend nearly 20% of its GDP on healthcare by 2017, a higher percentage than any other industrialized nation.
Wider adoption of cloud technologies and adoption of new advanced technologies play a major role in improving the market economy. Increasing aging populations and increased incidence of chronic diseases are also key factors driving the market. According to the National Institutes of Health, patients aged 65 and older undergo diagnostic imaging at two or more times the rate of younger people. Women also tend to use slightly higher rates of imaging than men. In spite of these factors driving the market, there are other factors constraining the growth of the market. Expensive procedures & equipment, side effects of diagnostic imaging procedures and saturation in the developed regions are the major challenges faced by the diagnostic imaging equipment market.
There are several new developments afoot in the medical imaging world. Imaging science is a dynamic, evolving field of multi- and interdisciplinary activities with a lot of scope and importance. Due to the increasing need to operate more efficiently and productively, medical imaging facilities will increasingly turn towards data analytics. There will be growing interest and demand for analytics solutions. PACS, RIS, and dictation systems are driving this market currently and are anticipated to emerge economically in coming years.
The market is segmented based on type (X-ray, MRI, nuclear medicine, ultrasound, tomography, tactile imaging, photoacoustic imaging, thermography, elastography, echocardiography, and functional near infrared spectroscopy). A few segments are sub-divided based on portability, structure, technology and resolution.
Tomosynthesis is another prominently used method. According to the Radiological Society of North America, tomosynthesis, or 3D mammography increases cancer detection and reduces the instances of the patient being called for further tests. 3D imaging is expected to grow in all markets during the forecast period. Manufacturers are showing a keen interest in improving image quality by exploiting new technologies and producing new instruments or novel techniques to achieve images with higher spatial resolution. Imaging will continue to advance and provide an essential set of tools for clinical research, drug development, disease diagnosis, treatment and assessing treatment response.
Based on geography, the global diagnostic imaging market is divided into North America, Europe, Asia-Pacific, Middle East & Africa and Latin America. Currently, North America dominates the market with nearly 20% of the gross domestic product spent on healthcare by the USA. Asia-Pacific is a market that is expected to grow at a faster rate, owing to the rapidly aging population and increase in the chronic disease population.
Medical imaging technology is a rapidly changing field, and healthcare organizations have multiple options for new acquisitions. Many players in this market are trying to expand their product portfolio in order to top the global market. A few companies have adopted product innovation and new product launches as their key business strategy to ensure their dominance in this market.
Major Companies in the Sector Include:
Market analysis for the diagnostic imaging market, with region specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
Identification and analysis of the macro and micro factors that affect the global diagnostic imaging market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
1.1 Study deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast period years
1.6 General Study Assumptions
2. Research Methodology
2.2 Analysis Methodology
2.3 Econometric Forecast Model
2.4 Research Assumptions
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry trends
5.1 Current Market Scenario
5.2 Porter's Five Forces
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat to new entrants
5.2.4 Threat to substitute products and services
5.2.5 Competitive Rivalry within the industry
6. Drivers, Restraints, Opportunities, and challenges Analysis
6.1 Market Drivers
6.1.1 Increasing Prevalence of Cancer, Cardiac/Brain disorders
6.1.2 Increasing geriatric population
6.1.3 Wider adoption of cloud technologies
6.1.4 Increased adoption of new advanced technologies by the medical industry
6.2 Market Restraints
6.2.1 Expensive procedures & equipment
6.2.2 Side effects of diagnostic imaging
6.2.3 Saturation in developed regions
6.3 Market Opportunities
6.3.1 Increasing Patient Pool
6.3.2 Advancement of Healthcare in developing countries
6.4 Market Challenges
6.4.1 Physicians choice for traditional CT/MRI over modern medical imaging equipment
6.4.2 Use of Refurbished Instruments
7. United States Diagnostic imaging Market segmentation
7.1 By type
188.8.131.52 By Portability
184.108.40.206.1 Digital Imaging
220.127.116.11.2 Analog Imaging
18.104.22.168 By Structure
22.214.171.124.1 Open MRI
126.96.36.199.2 Standing MRI
188.8.131.52 By Resolution
184.108.40.206.1 High - Field MRI Scanners
220.127.116.11.2 Low - Field MRI Scanners
18.104.22.168.3 Standup/Upright MRI Scanners
7.1.3 Nuclear Medicine
22.214.171.124 SPECT Imaging
126.96.36.199 PET Imaging
188.8.131.52 2D Ultrasound
184.108.40.206 3D Ultrasound
220.127.116.11 4D Ultrasound
18.104.22.168 Doppler Imaging
22.214.171.124 Computed Tomography Scanners
126.96.36.199.1 High End slice CT scanners
188.8.131.52.2 Mid End Slice CT Scanners
184.108.40.206.3 Low end slice CT scanners
7.1.6 Tactile Imaging
7.1.7 Photoacoustic Imaging
7.1.11 Functional near infrared spectroscopy
7.3 By Geography
7.3.1 North America
220.127.116.11 Spain & Portugal
18.104.22.168 South Korea
22.214.171.124 Australia & New Zealand
7.3.4 Latin America
7.3.7 Middle East & Africa
126.96.36.199 South Africa
8. Competitive Landscape
8.1 Merger and acquisition analysis
8.2 New Product Launches
8.3 Agreements, Collaborations and Partnerships
9. Key Vendor Analysis
9.1 Hitachi Medical Corporation
9.2 Philips Healthcare
9.3 GE Healthcare
9.4 Siemens Healthcare
9.5 Hologic, Inc.
9.6 Shimadzu Corporation
9.7 Toshiba Medical Systems
9.8 Fujifilm Holding
9.9 Esaote SpA
9.10 Carestream Health Inc.
9.11 Sonosite Inc.
11. Analyst outlook for Investment opportunities
12. Future Outlook of the market